JPWO2020221908A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020221908A5 JPWO2020221908A5 JP2021562803A JP2021562803A JPWO2020221908A5 JP WO2020221908 A5 JPWO2020221908 A5 JP WO2020221908A5 JP 2021562803 A JP2021562803 A JP 2021562803A JP 2021562803 A JP2021562803 A JP 2021562803A JP WO2020221908 A5 JPWO2020221908 A5 JP WO2020221908A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- nucleic acid
- seq
- acid molecule
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/061134 WO2020221450A1 (en) | 2019-04-30 | 2019-04-30 | Antibodies and methods for treatment of influenza a infection |
| EPPCT/EP2019/061134 | 2019-04-30 | ||
| PCT/EP2020/062160 WO2020221908A1 (en) | 2019-04-30 | 2020-04-30 | Antibodies and methods for treatment of influenza a infection |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022531556A JP2022531556A (ja) | 2022-07-07 |
| JP2022531556A5 JP2022531556A5 (https=) | 2023-05-02 |
| JPWO2020221908A5 true JPWO2020221908A5 (https=) | 2023-05-02 |
| JP7719725B2 JP7719725B2 (ja) | 2025-08-06 |
Family
ID=66429359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562803A Active JP7719725B2 (ja) | 2019-04-30 | 2020-04-30 | Ａ型インフルエンザ感染の抗体及び治療法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220226470A1 (https=) |
| EP (1) | EP3962530A1 (https=) |
| JP (1) | JP7719725B2 (https=) |
| KR (1) | KR20220003000A (https=) |
| CN (2) | CN114269381A (https=) |
| AU (1) | AU2020265407B2 (https=) |
| BR (1) | BR112021018409A2 (https=) |
| CA (1) | CA3132536A1 (https=) |
| CL (1) | CL2021002807A1 (https=) |
| CO (1) | CO2021012583A2 (https=) |
| EA (1) | EA202192923A1 (https=) |
| IL (1) | IL287423A (https=) |
| MX (1) | MX2021012984A (https=) |
| PH (1) | PH12021552176A1 (https=) |
| SG (1) | SG11202109683TA (https=) |
| TW (1) | TW202106707A (https=) |
| WO (2) | WO2020221450A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102820941B1 (ko) | 2018-01-26 | 2025-06-16 | 리제너론 파마슈티칼스 인코포레이티드 | 인플루엔자 헤마글루티닌에 대한 인간 항체 |
| IL290752B2 (en) * | 2019-08-29 | 2026-02-01 | Vir Biotechnology Inc | Preparations and methods for treating influenza a infection |
| US20230340083A1 (en) * | 2020-12-08 | 2023-10-26 | Vir Biotechnology, Inc. | Antibodies and methods for treatment of influenza a infection |
| CN112812095A (zh) * | 2021-01-29 | 2021-05-18 | 成都安满生物医药科技有限公司 | 一种巴洛沙韦酯中间体的合成方法 |
| WO2023201306A1 (en) | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | Compositions for preventing or treating influenza infections |
| CN115777944B (zh) * | 2023-02-10 | 2023-05-12 | 北京衡美金叶营养健康科技有限公司 | 增强身体防御力的组合物及其制备方法和应用 |
| IL325937A (en) * | 2023-07-24 | 2026-03-01 | Univ Miami | AAV-delivered antibodies and methods of using them |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| US8802820B2 (en) * | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| BRPI0914092B1 (pt) | 2008-10-22 | 2021-08-31 | Institute For Research In Biomedicine | Método de produção de um anticorpo a partir de células plasmáticas, método de produção de um anticorpo monoclonal a partir de células plasmáticas e método de produção de um anticorpo ou de um fragmento de anticorpo |
| US8326547B2 (en) | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
| EP2638072A4 (en) | 2010-11-12 | 2014-05-07 | Univ Rockefeller | FUSION PROTEINS FOR HIV THERAPY |
| JP6396313B2 (ja) | 2012-12-07 | 2018-09-26 | ファイザー・インク | 操作された単量体抗体断片 |
| EP3733244A1 (en) | 2013-10-02 | 2020-11-04 | Medlmmune, LLC | Neutralizing anti-influenza a antibodies and uses thereof |
| WO2017123685A1 (en) | 2016-01-13 | 2017-07-20 | Medimmune, Llc | Method of treating influenza a |
-
2019
- 2019-04-30 WO PCT/EP2019/061134 patent/WO2020221450A1/en not_active Ceased
-
2020
- 2020-03-04 TW TW109107093A patent/TW202106707A/zh unknown
- 2020-04-30 JP JP2021562803A patent/JP7719725B2/ja active Active
- 2020-04-30 WO PCT/EP2020/062160 patent/WO2020221908A1/en not_active Ceased
- 2020-04-30 CN CN202080034142.3A patent/CN114269381A/zh active Pending
- 2020-04-30 EP EP20721638.3A patent/EP3962530A1/en active Pending
- 2020-04-30 CA CA3132536A patent/CA3132536A1/en active Pending
- 2020-04-30 CN CN202411518877.XA patent/CN119192357A/zh active Pending
- 2020-04-30 KR KR1020217038260A patent/KR20220003000A/ko active Pending
- 2020-04-30 AU AU2020265407A patent/AU2020265407B2/en active Active
- 2020-04-30 SG SG11202109683TA patent/SG11202109683TA/en unknown
- 2020-04-30 BR BR112021018409A patent/BR112021018409A2/pt unknown
- 2020-04-30 EA EA202192923A patent/EA202192923A1/ru unknown
- 2020-04-30 US US17/607,383 patent/US20220226470A1/en active Pending
- 2020-04-30 MX MX2021012984A patent/MX2021012984A/es unknown
- 2020-04-30 PH PH1/2021/552176A patent/PH12021552176A1/en unknown
-
2021
- 2021-09-24 CO CONC2021/0012583A patent/CO2021012583A2/es unknown
- 2021-10-20 IL IL287423A patent/IL287423A/en unknown
- 2021-10-26 CL CL2021002807A patent/CL2021002807A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524267A5 (https=) | ||
| JP2020502996A5 (https=) | ||
| JP2018183173A5 (https=) | ||
| RU2017102514A (ru) | Гуманизированные анти-тау-антитела | |
| JP2019536430A5 (https=) | ||
| JP2019511911A5 (https=) | ||
| JP2017113028A5 (https=) | ||
| JP2019527194A5 (https=) | ||
| JP2018035138A5 (https=) | ||
| JP2019523753A5 (https=) | ||
| JP2015525795A5 (https=) | ||
| JP2016538876A5 (https=) | ||
| JP2016529882A5 (https=) | ||
| RU2012118636A (ru) | Молекула, специфически связывающаяся с rsv | |
| JP2021524478A5 (https=) | ||
| JP2017523805A5 (https=) | ||
| FI3525583T3 (fi) | Anti-c1s-vasta-aineita ja niiden käyttömenetelmiä | |
| JP2018514193A5 (https=) | ||
| RU2017104638A (ru) | Нейтрализующие антитела к вирусу гриппа B и пути их применения | |
| JPWO2020059847A5 (https=) | ||
| JP2016518333A5 (https=) | ||
| JP2017504321A5 (https=) | ||
| JP2018519804A5 (https=) | ||
| JP2021520393A5 (https=) | ||
| PE20221780A1 (es) | Composiciones y metodos para aumentar o mejorar la transduccion de vectores de terapia genica y para eliminar o reducir inmunoglobulinas |